KRAS mutations: an old oncogene becomes a new predictive biomarker.


This commentary highlights a novel assay for detection of mutations in KRAS, which have recently emerged as a useful negative predictive biomarker. 
DOI: 10.2353/jmoldx.2008.080105


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.